Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 147, Issue 9, Pages 2621-2624Publisher
SPRINGER
DOI: 10.1007/s00432-021-03707-2
Keywords
COVID-19; Low-dose radiation therapy; Pneumonia
Categories
Ask authors/readers for more resources
The study evaluated the effectiveness of low-dose radiation therapy (LDRT) in treating COVID-19 patients, showing an effectiveness rate of up to 90%. The majority of clinical trial investigations on LDRT for COVID-19 found it to be a feasible treatment to improve patient mortality.
Introduction Performing low-dose radiation therapy (LDRT) is a new approach to treat pneumonia resulting from COVID-19 disease. This paper aims to evaluate the effectiveness of LDRT in treating COVID-19 patients. Methods Medline was searched for low-dose and radiation therapy and COVID-19 and pneumonia and inflammation, to retrieve papers that published on low-dose radiation therapy to improve mortality of COVID-19 patients. Only clinical investigations that included original and case report papers were selected for this paper. Results The completed clinical trials that have performed LDRT to treat COVID-19 showed that the effectiveness of LDRT in treating COVID-19 was up to 90%. Conclusion The vast majority of primary and secondary outcomes of clinical trial investigations regarding LDRT in treating COVID-19 found that LDRT can be considered a feasible treatment to improve mortality of COVID-19 patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available